Abstract:Back in the year 2009, we presented in this journal a neonate with an unusual combination of congenital lactic acidosis and bilateral calcifications in the adrenal medulla 1 . After prenatal ultrasound examination at 21 weeks had revealed intrauterine growth retardation and pericardial effusions, labor was induced at 38 weeks of pregnancy. The patient was hypotonic at birth, had respiratory insufficiency necessitating intubation and artificial ventilation, hepatomegaly and severe cardiomegaly. Intensive care was withdrawn in accordance with parents' wishes on day 38. At the time, the patient's causal genetic defect had remained unknown, yet clinical and biochemical evidence ticked all the boxes of an underlying mitochondrial defect. Postmortem spectrophotometric evaluation then revealed decreased oxidative phosphorylation activities in heart muscle (complex IV) and liver (complexes I, III, IV and V), and normal activities in skeletal muscle and cultured skin fibroblasts. Blue-native polyacrylamide gel electrophoresis of liver extracts confirmed decreased activities of complexes III and IV and showed the presence of subcomplexes of complex V. Thanks to the great genetic leap forward taken by medical research ever since, we were now able to thoroughly investigate the patient's whole exome extracted from preserved cultured skin fibroblasts. These investigations picked up compound heterozygous missense variants in the gene encoding the mitochondrial leucyl-tRNA synthetase ( LARS2 ): c.302 A > G (p.His101Arg) and c.516 G > T (p.Arg172Ser). Nuclear-encoded mitochondrion-specific aminoacyl-tRNA synthetases exist for 17 of the 20 proteogenic amino acids, and pathogenic mutations have now been reported for each one of these 2 . At the time we published our casus, LARS2 defects had not been reported, yet between the year 2013 and now, a total of 23 patients have been described that carry disease-causing LARS2 variants (Table 1) 1,3,4,5,6,7,8,9,10,11,12,13 . Their diverse associated disease phenotypes, which include Perrault syndrome, multisystem disease, leukodystrophy and intellectual disability, do not appear to have an obvious link with genotype. With the casus we presented in this journal and now have characterized at the molecular level, more than twenty patients with 18 unique combinations of disease-causing LARS2 variants have been reported so far, only one was homozygous the others concerned compound heterozygous variants. Table 1 Published patients carrying disease-causing LARS2 variants. Full size table

A homozygous TARS2 variant is a novel cause of syndromic neonatal diabetes

Trna Methyltransferase 10 Homologue A (TRMT10A) Mutation in a Chinese Patient with Diabetes, Insulin Resistance, Intellectual Deficiency and Microcephaly

Clinical, neuroradiological, and molecular characterization of mitochondrial threonyl-tRNA-synthetase (TARS2)-related disorder

TARS2 c.470 C > G is a chinese-specific founder mutation in three unrelated families with mitochondrial encephalomyopathy

Whole-exome sequencing in familial type 2 diabetes identifies an atypical missense variant in the RyR2 gene

Discovery of a TRMT10A mutation in a case of atypical diabetes: case report

TARS2 Variants Cause Combination Oxidative Phosphorylation Deficiency-21: A Case Report and Literature Review

WARS1 and SARS1 : Two Trna Synthetases Implicated in Autosomal Recessive Microcephaly

Neonatal lactic acidosis explained by LARS2 defect

Expanding the mutational spectrum of in Turkish pediatric population

Homozygous deletion of TRMT10A as part of a contiguous gene deletion in a syndrome of failure to thrive, delayed puberty, intellectual disability and diabetes mellitus

Functional analysis of the novel mitochondrial tRNA Trp and tRNA Ser(AGY) variants associated with type 2 diabetes mellitus

Identification of a novel TSC1 variant in a family with developmental and epileptic encephalopathies: A case report and literature review

A Missense Mutation in IRS1 is Associated with the Development of Early-Onset Type 2 Diabetes

Severe Epilepsy in an Individual with a TSC2 R905Q Variant Prompting Late Diagnosis in Affected Family Members

The Identification of a Novel Pathogenic Variant in the GATA6 Gene in a Child with Neonatal Diabetes

Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6

Excess maternal transmission of variants in the THADA gene to offspring with type 2 diabetes

Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report

De Novo Pathogenic Variant in FBRSL1, Non OMIM Gene Paralogue AUTS2, Causes a Novel Recognizable Syndromic Manifestation with Intellectual Disability; An Additional Patient and Review of the Literature

Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy